Cristina Moreno1, Alicia de la Cruz2, Anna Oliveras3, Sanjay R Kharche4, Miriam Guizy2, Nùria Comes3, Tomáš Starý4, Carlotta Ronchi5, Marcella Rocchetti5, Isabelle Baró6, Gildas Loussouarn6, Antonio Zaza5, Stefano Severi4, Antonio Felipe3, Carmen Valenzuela1. 1. Instituto de Investigaciones Biomédicas 'Alberto Sols' CSIC-UAM, C/Arturo Duperier 4, 28029 Madrid, Spain cvalenzuela@iib.uam.es c.moreno@maastrichtuniversity.nl. 2. Instituto de Investigaciones Biomédicas 'Alberto Sols' CSIC-UAM, C/Arturo Duperier 4, 28029 Madrid, Spain. 3. Molecular Physiology Laboratory, Departament de Bioquímica i Biologia Molecular, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, Spain. 4. Biomedical Engineering Laboratory D.E.I.S., University of Bologna, 47521 Cesena, Italy. 5. Department of Biotechnologies and Biosciences, University of Milano-Bicocca, Milan, Italy. 6. L'Institut du Thorax, Unité Inserm UMR 1087/CNRS UMR 6291, Nantes, France.
Abstract
AIMS: Polyunsaturated fatty n-3 acids (PUFAs) have been reported to exhibit antiarrhythmic properties. However, the mechanisms of action remain unclear. We studied the electrophysiological effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on IKs, and on the expression and location of Kv7.1 and KCNE1. METHODS AND RESULTS: Experiments were performed using patch-clamp, western blot, and sucrose gradient techniques in COS7 cells transfected with Kv7.1/KCNE1 channels. Acute perfusion with both PUFAs increased Kv7.1/KCNE1 current, this effect being greater for DHA than for EPA. Similar results were found in guinea pig cardiomyocytes. Acute perfusion of either PUFA slowed the activation kinetics and EPA shifted the activation curve to the left. Conversely, chronic EPA did not modify Kv7.1/KCNE1 current magnitude and shifted the activation curve to the right. Chronic PUFAs decreased the expression of Kv7.1, but not of KCNE1, and induced spatial redistribution of Kv7.1 over the cell membrane. Cholesterol depletion with methyl-β-cyclodextrin increased Kv7.1/KCNE1 current magnitude. Under these conditions, acute EPA produced similar effects than those induced in non-cholesterol-depleted cells. A ventricular action potential computational model suggested antiarrhythmic efficacy of acute PUFA application under IKr block. CONCLUSIONS: We provide evidence that acute application of PUFAs increases Kv7.1/KCNE1 through a probably direct effect, and shows antiarrhythmic efficacy under IKr block. Conversely, chronic EPA application modifies the channel activity through a change in the Kv7.1/KCNE1 voltage-dependence, correlated with a redistribution of Kv7.1 over the cell membrane. This loss of function may be pro-arrhythmic. This shed light on the controversial effects of PUFAs regarding arrhythmias. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Polyunsaturated fatty n-3 acids (PUFAs) have been reported to exhibit antiarrhythmic properties. However, the mechanisms of action remain unclear. We studied the electrophysiological effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on IKs, and on the expression and location of Kv7.1 and KCNE1. METHODS AND RESULTS: Experiments were performed using patch-clamp, western blot, and sucrose gradient techniques in COS7 cells transfected with Kv7.1/KCNE1 channels. Acute perfusion with both PUFAs increased Kv7.1/KCNE1 current, this effect being greater for DHA than for EPA. Similar results were found in guinea pig cardiomyocytes. Acute perfusion of either PUFA slowed the activation kinetics and EPA shifted the activation curve to the left. Conversely, chronic EPA did not modify Kv7.1/KCNE1 current magnitude and shifted the activation curve to the right. Chronic PUFAs decreased the expression of Kv7.1, but not of KCNE1, and induced spatial redistribution of Kv7.1 over the cell membrane. Cholesterol depletion with methyl-β-cyclodextrin increased Kv7.1/KCNE1 current magnitude. Under these conditions, acute EPA produced similar effects than those induced in non-cholesterol-depleted cells. A ventricular action potential computational model suggested antiarrhythmic efficacy of acute PUFA application under IKr block. CONCLUSIONS: We provide evidence that acute application of PUFAs increases Kv7.1/KCNE1 through a probably direct effect, and shows antiarrhythmic efficacy under IKr block. Conversely, chronic EPA application modifies the channel activity through a change in the Kv7.1/KCNE1 voltage-dependence, correlated with a redistribution of Kv7.1 over the cell membrane. This loss of function may be pro-arrhythmic. This shed light on the controversial effects of PUFAs regarding arrhythmias. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Sara I Liin; Malin Silverå Ejneby; Rene Barro-Soria; Mark Alexander Skarsfeldt; Johan E Larsson; Frida Starck Härlin; Teija Parkkari; Bo Hjorth Bentzen; Nicole Schmitt; H Peter Larsson; Fredrik Elinder Journal: Proc Natl Acad Sci U S A Date: 2015-04-21 Impact factor: 11.205
Authors: Alessandro Castiglione; Tibor Hornyik; Eike M Wülfers; Lucilla Giammarino; Iask Edler; Jessica J Jowais; Marina Rieder; Stefanie Perez-Feliz; Gideon Koren; Zsuzsanna Bősze; András Varró; Manfred Zehender; Michael Brunner; Christoph Bode; Sara I Liin; Hans Peter Larsson; István Baczkó; Katja E Odening Journal: Europace Date: 2022-03-02 Impact factor: 5.486
Authors: Alicia de la Cruz; Alba Vera-Zambrano; Diego A Peraza; Carmen Valenzuela; Juan M Zapata; Gema Perez-Chacon; Teresa Gonzalez Journal: Front Pharmacol Date: 2017-03-31 Impact factor: 5.810
Authors: Ingrid M Bonilla; Yoshinori Nishijima; Pedro Vargas-Pinto; Stephen H Baine; Arun Sridhar; Chun Li; George E Billman; Cynthia A Carnes Journal: Front Physiol Date: 2016-06-14 Impact factor: 4.566